Newsfile Corp
23 Oct 2026, 07:50 UTC · 2h ago
Kaplan Fox Notifies Unicycive Therapeutics, Inc. (UNCY) Investors of a Pending Securities Class Action Deadline on November 2, 2026
Impact · against what's priced in
Unicycive Therapeutics faces potential financial headwinds due to a newly announced securities class action lawsuit. This introduces legal liability and potential settlement costs that could weigh on the company's balance sheet through 2027.
- UNCY−0.30
No priced-in read yet





